- Home
- HIHO vs CYCN Comparison
HIHO vs CYCN Comparison
Compare HIHO & CYCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HIHO
- CYCN
- Stock Information
- Founded
- HIHO 1990
- CYCN 2018
- Country
- HIHO Hong Kong
- CYCN United States
- Employees
- HIHO N/A
- CYCN N/A
- Industry
- HIHO Industrial Machinery/Components
- CYCN Biotechnology: Pharmaceutical Preparations
- Sector
- HIHO Industrials
- CYCN Health Care
- Exchange
- HIHO Nasdaq
- CYCN Nasdaq
- Market Cap
- HIHO 7.6M
- CYCN 8.0M
- IPO Year
- HIHO 1996
- CYCN N/A
- Fundamental
- Price
- HIHO $1.73
- CYCN $2.45
- Analyst Decision
- HIHO
- CYCN
- Analyst Count
- HIHO 0
- CYCN 0
- Target Price
- HIHO N/A
- CYCN N/A
- AVG Volume (30 Days)
- HIHO 199.8K
- CYCN 25.2K
- Earning Date
- HIHO 09-11-2025
- CYCN 11-13-2025
- Dividend Yield
- HIHO 7.06%
- CYCN N/A
- EPS Growth
- HIHO N/A
- CYCN N/A
- EPS
- HIHO 0.01
- CYCN N/A
- Revenue
- HIHO $7,080,000.00
- CYCN $2,174,000.00
- Revenue This Year
- HIHO N/A
- CYCN N/A
- Revenue Next Year
- HIHO N/A
- CYCN N/A
- P/E Ratio
- HIHO $176.02
- CYCN N/A
- Revenue Growth
- HIHO 3.31
- CYCN N/A
- 52 Week Low
- HIHO $1.40
- CYCN $1.27
- 52 Week High
- HIHO $2.88
- CYCN $9.47
- Technical
- Relative Strength Index (RSI)
- HIHO 54.06
- CYCN 48.35
- Support Level
- HIHO $1.59
- CYCN $2.13
- Resistance Level
- HIHO $1.83
- CYCN $2.62
- Average True Range (ATR)
- HIHO 0.11
- CYCN 0.23
- MACD
- HIHO 0.00
- CYCN 0.02
- Stochastic Oscillator
- HIHO 37.50
- CYCN 42.13
About HIHO Highway Holdings Limited
Highway Holdings Ltd is a holding company. Along with its subsidiaries, it operates as a fully integrated manufacturer of high-quality metal, plastic, electric and electronic components, subassemblies, and finished products for OEMs and contract manufacturers. The manufacturing services offered by the group include metal stamping, screen printing, plastic injection molding, pad printing, and electronic assembly of printed circuit boards. Its reportable business segments are metal stamping and mechanical OEM operations, which derive maximum revenue, and electric OEM operations. Geographically, the group generates maximum revenue from Europe, and the rest from North America, Hong Kong and China, and other Asian countries.
About CYCN Cyclerion Therapeutics Inc.
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.